HCPLive Network

New Research Is Changing the Clinical Perception of Chronic Pancreatitis

 
New information about the cause and treatment of chronic pancreatitis sheds light on old ways of thinking about the condition, according to Christopher Forsmark, MD, who addressed the subject this week during a joint conference of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy in Coronado, California.
 
Researchers have identified several mutations of genes that could predispose someone to chronic pancreatitis. Chronic alcohol abuse is no longer considered the main culprit of the condition, particularly in women, but that news has not reached everyone in the business of health care, said Forsmark.
 
Patients are often still asked about their drinking habits when they seek treatment for symptoms. “They go to the ER, and the first thing the nurse says is, ‘How much do you drink?’ When they say, ‘I don’t drink,’ nobody believes them,” said Forsmark. “
 
While it is still an important contributing factor, alcohol consumption is now much less commonly identified as the cause of chronic pancreatitis. According to studies that tried to quantify how many daily alcoholic drinks would lead to the condition, the answer is “a lot,” said Forsmark, roughly five a day for five to 10 years.


Further Reading
Researchers assessed the effect of seizure status and severity, medication use, mental health indicators, parental support, and other factors on self-reported quality of life in children with epilepsy.
A group of international researchers led by Luosheng Li, MD, of the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institutet, Karolinska University Hospital in Stockholm, Sweden, recently demonstrated that age-dependent decline in insulin secretion (and thus glucose homeostasis) from the beta cell in experimental mice models is associated with subtle changes in Ca2+ dynamics.
For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), the right treatment can make a world of difference in the management of their condition. A recent study looked at how effective inhaled budesonide and systemic methylprednisolone can be for those patients.
More Reading
Researchers assessed the effect of seizure status and severity, medication use, mental health indicators, parental support, and other factors on self-reported quality of life in children with epilepsy.